Two years ago, the UK became the first country to approve Casgevy, a Crispr-based therapy for the blood disorders sickle cell disease and β-thalassaemia. This year saw the world’s first personalised ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...
This is not the finest hour for human rights, says 2025 CBC Massey Lecturer Alex Neve. But it still could be. The Universal Declaration of Human Rights was created 1948, after the untold carnage and ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback